Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated to version v3.6.3, representing a small update to the page's template or backend tracking rather than any substantive change to the study details.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor backend/content-management update. No study information or user-facing content is affected.SummaryDifference0.1%

- Check26 days agoChange DetectedResults and related outcomes for the trial were posted, including Recurrence-free Survival, Overall Survival, DMFS, and CTCAE v5.0 adverse events, and a PDF of the Study Protocol and Statistical Analysis Plan was provided. The entries detailing previous result estimation text were removed.SummaryDifference2%

- Check33 days agoChange DetectedNew recruitment status note 'No longer looking for participants' and guidance sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the 'Intervention / Treatment' heading was standardized to 'Intervention/Treatment'. The footer revision label was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check40 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a small maintenance/update to the page metadata rather than a substantive content change.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s revision history now shows a new version, v3.5.4, replacing the previous v3.5.3. This update signals a new publication of the page and primarily affects metadata rather than the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.